Abstract:The magnitude of the response to a specific immunogen such as an infectious agent is the result of a complex interaction between genetic and environmental factors. For example, in intestinal inflammation, the inflammatory response appears to be regulated by the indigenous microflora of the gut, by receptors in epithelial cells and antigen-presenting cells in the intestinal mucosa, and by immunologic factors. Recent evidence suggests that genetic variants of human immunomodulating genes influence the susceptibility to and severity of infectious diseases and the subsequent clinical outcome of disease. This review will focus on recently identified pattern recognition receptors which are located on innate immune and epithelial cells, and recognize pathogen-associated molecular patterns. The binding of specific pathogen-associated molecular patterns to these receptors results in the activation of a signal transduction pathway through nuclear factor (NF)-kappaB which leads to either enhanced or inhibited immune responses that modify the production of inflammatory effectors, such as cytokines. This article reports on the identification and functional characterization including the discovery of mutants which completely abolish NF-kappaB signal transduction of pattern recognition receptors, such as the extracellular Toll-like receptors and the intracellular nucleotide oligomerization domain/caspase recruitment domain (NOD/CARD) receptors, as well as their role in clinical disease. Knowledge of pattern recognition receptors such as Toll-like receptors and NOD/CARD intracytoplasmic proteins, including their functions and their downstream signaling pathways, may provide a new molecular basis for preventing or blocking inflammation associated with pathogenic microorganisms. This could direct a new focus for better and more specific therapeutic treatments based on immuno-intervention that can promise a better quality of life for those suffering from chronic disturbances of the immune response.

NOD2 signaling and role in pathogenic mycobacterium recognition, infection and immunity.

[Progress on Mechanisms for Pathogensto Evade NOD-like Receptor and Toll-like Receptor Signaling Pathways].

NOD2, RIP2 and IRF5 Play a Critical Role in the Type I Interferon Response to Mycobacterium tuberculosis

Androgen ablation in addition to radiation therapy for prostate cancer: is there true benefit?

Identification of Mycoplasma pneumoniae proteins interacting with NOD2 and their role in macrophage inflammatory response

NOD1 and NOD2: Essential Monitoring Partners in the Innate Immune System

Deviant Behavior: Tick-Borne Pathogens and Inflammasome Signaling.

NOD1, NOD2, and NLRC5 Receptors in Antiviral and Antimycobacterial Immunity

Role and molecular mechanism of NOD2 in chronic non-communicable diseases

Recognition of Gut Microbiota by NOD2 is Essential for the Homeostasis of Intestinal Intraepithelial Lymphocytes.

Two years follow-up Cottbus reinfarction study with 30 and 60 mg acetylsalicylic acid.

NOD proteins and immune response

Nucleotide-oligomerizing domain-1 (NOD1) receptor activation induces pro-inflammatory responses and autophagy in human alveolar macrophages

Mycoplasma hyopneumoniae Infection Activates the NOD1 Signaling Pathway to Modulate Inflammation

Impact of industrial effluents on geochemical association of metals within intertidal sediments of a creek.

Activation of Both TLR and NOD Signaling Confers Host Innate Immunity-Mediated Protection Against Microbial Infection

The Role of TLR2 in Infectious Diseases Caused by Mycobacteria: From Cell Biology to Therapeutic Target

Toll-like receptors and NOD/CARD proteins: pattern recognition receptors are key elements in the regulation of immune response

NF-κB signaling deficiency in CD11c-expressing phagocytes mediates early inflammatory responses and enhances Mycobacterium tuberculosis control

Innate immunity in tuberculosis: host defense vs pathogen evasion

Microbial ligand-independent regulation of lymphopoiesis by NOD1